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Background: The validity of survey-based health care utilization estimates in the older population has been
poorly researched. Owing to data protection legislation and a great number of different health care insurance
providers, the assessment of recall and non-response bias is challenging to impossible in many countries. The
objective of our study was to compare estimates from a population-based study in older German adults with
external secondary data.
Methods: We used data from the German KORA-Age study, which included 4,127 people aged 65–94 years.
Self-report questions covered the utilization of long-term care services, inpatient services, outpatient services, and
pharmaceuticals. We calculated age- and sex-standardized mean utilization rates in each domain and compared
them with the corresponding estimates derived from official statistics and independent statutory health
insurance data.
Results: The KORA-Age study underestimated the use of long-term care services (−52%), in-hospital days (−21%)
and physician visits (−70%). In contrast, the assessment of drug consumption by postal self-report questionnaires
yielded similar estimates to the analysis of insurance claims data (−9%).
Conclusion: Survey estimates based on self-report tend to underestimate true health care utilization in the older
population. Direct validation studies are needed to disentangle the impact of recall and non-response bias.
Keywords: Health care utilization, Self-report, Validity, Survey, Response bias, Recall bias, Claims dataBackground
According to population forecasts, one third of the
German resident population will be aged 65 or older in
2050 [1]. Thus, studies on resource utilization in the eld-
erly population will gain in importance for reasons of fi-
nancing and health services research. Health insurance
claims data are generally considered to provide the most
precise information on service utilization and costs [2].
In many countries, however, linking health surveys with
administrative data is challenging if not impossible [3].* Correspondence: matthias.hunger@helmholtz-muenchen.de
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reproduction in any medium, provided the orIn Germany, for example, no single source exists for re-
source utilization data. Thus, researchers have to contact
numerous payers and service providers to collect com-
prehensive data, making this approach costly and time-
consuming in practice [4,5].
A common alternative to estimating service utilization
are population-based surveys with retrospective self-
reports. Although such methods are easy to apply in
practice, the information obtained may be biased due to
poor recall of past events [6]. Studies have shown that
recall of resource utilization declines over time and that
some components of healthcare utilization may be
recalled better than others [2,7].
Another problem with survey research is the possible
non-response bias, which occurs if there are differentl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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who were invited but did not respond [8-10]. Direct assess-
ment of non-response bias is only feasible if administrative
data from both, survey participants and non-responders
are available. In many countries, however, obtaining health
care information about non-responders without their con-
sent is not possible on account of national data protection
legislation.
In Germany, several surveys on health care utilization in
the elderly have been conducted in recent years [11-13].
However, given the above hurdles for linking individual
survey data to administrative data and the prohibition on
using non-responder data without consent, studies on the
impact of recall and non-response bias are largely lacking.
The second best alternative in evaluating the accuracy of
estimates is to compare summary statistics from the sur-
vey with corresponding summary statistics from other
sources such as official statistics and insurance data
[14,15]. However, we know of no German study that has
yet undertaken such a comparison. Evaluating potential
biases is especially important for surveys in the older
population where recall may be worse than in younger
ages, and where non-response may be caused by illness or
disability which in turn is a predictor of higher utilization
levels [16].
The purpose of this study was to compare estimates of
health care utilization calculated from the population-
based German KORA-Age study with corresponding
estimates obtained from official statistics and an inde-
pendent statutory health insurance sample.
Methods
KORA-Age study
The KORA-Age study was conducted between December
2008 and October 2009 as a longitudinal study fo-
cusing on research into multimorbidity in the older
population. The study design was based on ongoing
studies from KORA research, a platform for population-
based surveys and subsequent follow-up studies in the
fields of epidemiology, health economics and health care
research in Germany [17]. The KORA-Age study is a
follow-up of all participants aged 65–94 in the MONICA/
KORA surveys S1 to S4 conducted between 1984 and
2001. In these surveys, participants were randomly
selected from population registries in the study region,
comprising the city of Augsburg and its two surrounding
counties in the federal state of Bavaria. Participation rates
ranged between 79% and 67%. Details about study design,
sampling method and data collection can be found else-
where [17-19]. In total, 17,607 people participated in at
least one of the four surveys. The KORA-Age study popu-
lation is restricted to the subgroup of 9,197 subjects born
in 1943 or earlier. Of these, 2,734 individuals had died, 45
had moved away and 427 refused to be contacted for anyfollow-up, resulting in 5,991 eligible people with known
addresses.
The KORA-Age study combined two designs. First, a
morbidity follow-up questionnaire covering major dis-
eases and drug utilization was sent by post to all 5,991
eligible individuals. Second, a 30-minute telephone inter-
view with more in-depth questions was conducted about
2 weeks after the return of the questionnaire, in which
participants were also asked about their utilization of
outpatient, inpatient and long-term care services. If a
telephone interview was not possible, individuals were
offered the chance to be interviewed at home. The ques-
tions could also be answered by a proxy (i.e. a family
member or professional care giver) if the respondent
was unable to participate.
In total, 4,127 interviews on resource utilization were
performed (response 68.9%), of which 60 were per-
formed at the participants’ home and 185 were proxy
interviews.
Assessment of resource use
Questions on health service utilization in the KORA-
Age study covered inpatient services, outpatient services,
drug utilization, and long-term care services according
to the scope of compulsory long-term care insurance
(LTCI) [20,21] The first three domains are covered by
the Statutory Health Insurance (SHI) and the last by
LTCI, which is a separate branch within the German so-
cial security system covering various community-based
and institutional nursing care services. LTCI defines
three care levels reflecting the applicant’s need for sup-
port in activities of daily living. Each level is connected
to a fixed monthly tariff for community-living and insti-
tutionalized beneficiaries.
Long-term care utilization in the KORA-Age study
was assessed by asking ‘Did you use services covered by
the LTCI in the past 12 months?’ and, if ‘yes’, ‘Which
care level are you assigned to?’.
For inpatient services, the number of hospital days was
assessed by asking ‘Have you been hospitalized in the past
12 months?’ and, if ‘yes’, ‘How many days have you been
hospitalized in the past 12 months?’. Outpatient services
were assessed by asking the question, ‘How often did you
see a physician (general practitioner or specialist) in the
past 3 months?’. Finally, drug consumption was assessed
in the postal questionnaire and covered the medications
taken in the past 7 days including both prescribed and
over-the-counter (OTC) drugs. Participants were asked to
write down the exact name and central pharmaceutical
number (PZN) for each medication. The PZN is a nation-
wide standardized identification number for proprietary
medical products in Germany enabling a well-defined
attribution of a pharmaceutical product including, for ex-
ample, name, package size and defined daily dose (DDD).
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Data used for external comparison come from independ-
ent insurance claims data and official statistics.
The insurance data used for comparison refer to an
excess cost study with dementia patients and non-
demented control subjects conducted by Schwarzkopf
et al. [22]. The corresponding sample was provided by
AOK Bavaria, a large local SHI fund, from which we
obtained permission to reuse the data in our analyses. It
provided 2005 to 2007 claims data for its insured clients
living in the Bavarian district of Middle Franconia who
were aged 65 years and older in 2006. AOK is the lead-
ing SHI fund in that district, covering about 50% of the
population in the respective age range. For the design of
the above study, each insured person with diagnosed
dementia was matched with four non-demented control
subjects. As the objective of the present study was to
estimate utilization rates for the general population, we
recreated the original dementia prevalence in each
5-year age and sex group by deleting the supernumerous
dementia patients per group. This led to a final insur-
ance sample of 37,546 insured people. We analysed the
2006 claims data rather than the more recent 2007 data
because the original matching of demented and non-
demented individuals was based on the 2006 data and
because using the 2007 data would result in losing
claims data on individuals aged 65 years.
AOK claims data were used as a comparator for all
four utilization domains in the KORA-Age study. We
also compared estimates of long-term care utilization
with published official reports that are freely available
from the Bavarian Office for Statistics and Data Proces-
sing [23,24]. These reports provide information on the
total number of LTCI beneficiaries and their care levels
in Bavaria in 2009.
A comparison between utilization estimates from the
above data sources requires the consideration of three
major methodological differences between them. First,
data were partly collected at different times: Whereas
the majority of KORA-Age participants were assessed in
2009 and the official statistics on long-term care
utilization also refer to 2009, the AOK claims data date
back to 2006. Published statistics showed that, with the
exception of long-term care use, utilization of health
care services has increased during this 3-year period
[25,26]. This was most pronounced for pharmaceuticals
[27,28]. Second, although all data sources refer to people
residing in Bavaria, several only focus on specific
Bavarian counties or districts: Whereas the KORA-Age
study was conducted in the city of Augsburg and its two
surrounding counties, the insurance data comprise indi-
viduals from the district of Middle Franconia. The loca-
tion of the different geographical entities in question
is depicted in Figure 1. Third, the three data sourcesdiffer slightly with respect to the reference population
they are targeting: Whereas the KORA-Age study was
conducted in the general population with German na-
tionality, the official statistics as well as the AOK claims
data also include non-German individuals. Furthermore,
given that AOK Bavaria is an SHI, the data do not com-
prise individuals insured with private health insurance
companies traditionally chosen by the wealthier popula-
tion – these make up less than 10% of the general popu-
lation aged 65 and older.
To address the above methodological differences ap-
propriately, we proceeded as follows. To examine poten-
tial differences between the geographical entities, we
compared official statistics on the distribution of age,
sex and morbidity in the KORA study region in 2009
and the district of Middle Franconia in 2006 with the
respective statistics for the Federal State of Bavaria in
2006 and 2009. To adjust for the development of health
expenditures between 2006 and 2009, we calculated
domain-specific correction factors as follows. For in-
patient and outpatient domains, we extrapolated the
observed growth rates in the AOK claims data between
2006 and 2007 to the year 2009. For drug utilization, we
applied a very thorough extrapolation method based on
published national age- and anatomical therapeutic
chemical (ATC)-specific growth rates in the consump-
tion of DDD [27,28]. As a sensitivity analysis, we also
displayed unextrapolated 2006 data within our tables.
Given that utilization rates for long-term care remained
stable between 2006 and 2009, we did not extrapolate
2006 values [23,24] . Finally, when comparing estimates
from the KORA-Age study with those derived from the
AOK claims data, we excluded all non-German indivi-
duals in the AOK sample and all KORA-Age subjects
who were privately insured. Moreover, we restricted
presentation of our results to individuals aged between
65 and 90 years because only nine KORA-Age partici-
pants were older than 90 years.
As AOK insures a higher proportion of individuals
with lower socio-economic status compared with other
health insurance funds and as this may be associated
with higher health service use, we conducted another
sensitivity analysis in which we only considered KORA-
Age participants insured by the AOK. As the name of
the health insurance fund was not assessed in the
KORA-Age study, we used this information from the
baseline surveys.
Comparison of resource use components
For each domain and in each data source, we first calcu-
lated utilization rates stratified by 5-year age and sex
groups and then calculated standardized rates using the
sex and age distribution in Bavaria 2009 as a reference
population.
Figure 1 Location of Middle Franconia and the KORA study region in the state of Bavaria.
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In the long-term care domain, we compared the esti-
mates from the entire KORA-Age sample with the
estimates derived from the official Bavarian statistics.
For comparison with the AOK data, we excluded all
KORA-Age subjects with private health insurance. We
calculated the overall percentage of individuals entitled
to LTCI services and their distribution over the three
different care levels.
Inpatient services
In the inpatient domain we calculated the mean number
of hospital days per individual. Information on hospital
treatment in claims data includes all services provided
by a hospital (inpatient services, day-care services, out-
patient surgery and ambulatory emergency treatment).
In contrast, the KORA-Age questionnaire exclusively
targeted inpatient services, requiring at least one over-
night stay. To ensure comparability, we identified in-
patient hospital treatment from the claims data via
billing and documentation characteristics.Outpatient services
Considering the outpatient domain in the AOK data, we
calculated the number of physician visits per year. It is
noteworthy that these ‘visits’ do not necessarily require
direct patient–physician interaction but also include
repeat prescriptions. To obtain a comparable measure in
the KORA-Age study, we extrapolated the number of
visits assessed for one quarter to 12 months by multiply-
ing it by 4.
Drug utilization
The comparison of drug utilization rates between a
health survey and insurance data is not straightforward
[29]. First, the KORA-Age study gives a 7-day ‘snapshot’
of the medication currently used by each participant,
whereas the AOK data only provide information on
which date a medical prescription was filled. Thus, it is
challenging to determine over what time horizon indivi-
duals take the corresponding drug or even how many
drugs are taken at the same time [30]. Second, insurance
data only contain pharmaceuticals that are reimbursed
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participants in the KORA-Age study were asked to
report any kind of medication, which also included OTC
drugs. Third, drug utilization rates may be difficult to
compare because of different package sizes.
In order to establish a sensible standard of comparison,
our measure of interest was the number of drugs from dif-
ferent pharmaceutical groups for the treatment of major
chronic conditions that individuals take at the same time.
We restricted our analyses to drugs for chronic conditions
because they are more comparable across the two data
sources than drugs used as needed [29,31]. Moreover,
chronic conditions require continuous pharmacological
treatment; thus different package sizes and the reach of
one single prescription are no longer relevant. The dis-
eases considered in our analyses were those listed in the
classification of medications for chronic conditions pub-
lished by Lamers and van Vliet [32]. Their algorithm
identifies chronic conditions on the basis of ATC codes of
the medicaments typically used to treat them. For ex-
ample, an individual is identified as having diabetes if she/
he is taking drugs with ATC code A10A (insulins) or
A10B (oral blood glucose-lowering drugs). We excluded
OTC drugs from the KORA-Age study because these are
not documented in insurance claims data. In order to have
a time span in the AOK data that is comparable to the
‘snapshot’ character of the data in the KORA-Age study,
we only considered prescriptions that AOK insurants filled
during the second quarter of 2006. We chose this
3-month time span for two reasons. On the one hand, we
wanted the reference time span to be as short as possible.
On the other hand, it needs to be long enough to provide
records on each drug used to treat a chronic condition
[33]. As the largest package size covers a maximum of
3 months, a patient with a chronic condition has to fill a
prescription at least once per quarter. The 3-month period
has shown high sensitivity compared with shorter periods
for capturing the use of medicines for chronic conditions
[29,33].
In summary, the number of drugs taken to treat
chronic conditions in the AOK claims data was calcu-
lated as follows. First, all drugs prescribed during the
reference quarter were grouped according to the ATC
groups defined by Lamers and van Vliet [32]. Second,
drugs per therapeutic subgroup were only counted once
even if they were prescribed more than once during the
reference period. This is to ensure that subsequent pre-
scriptions of two small packs are considered equivalent
to the prescription of one big pack. This approach may
lead to a conservative estimate for the number of drugs
because it does not account for combination therapies of
drugs within the same ATC subgroup. For example,
an insured person with diabetes combining insulin and
oral anti-diabetic agent therapy is assigned two differentdrugs (A10A and A10B respectively), whereas a patient
combining two different oral anti-diabetic agents is only
assigned one drug.
As exactly the same method was applied to the reim-
bursed drugs reported by the KORA-Age participants,
possible underestimation for combination therapies only
affects the level of drug consumption, not the compari-
son between the data sources.Comparison between individuals with and without
diabetes
In addition to considering the overall level of health care
utilization, it is also interesting to examine whether
health surveys validly estimate differences between vari-
ous groups of individuals, e.g. between those with and
without a certain disease. We addressed this question
using diabetes as an example because diabetes has a high
prevalence in older adults and is known to be a signifi-
cant economic burden to health care systems.
To ensure consistency in the identification of diabetes
between survey and insurance data, we only considered
subjects who received oral anti-diabetic drugs or insulin
(ATC code A10). The alternative would have been to
consider physician diagnoses in the claims data and
self-reports in the survey data. However, we considered
this approach to be more likely to be subject to bias as
some people with physician-diagnosed diabetes may not
report having the disease and documentation of dia-
betes by the physician may not always be complete [34].
We calculated the ratio of age- and sex-adjusted mean
utilization rates (number of hospital days and number
of physician visits per year) between individuals with
and without diabetes in the KORA-Age study and com-
pared this ratio with the respective estimate from the
AOK insurance data. The mean utilization rates were
estimated using a linear model adjusting for sex and age
groups and holding these covariates fixed at the corre-
sponding mean values of the Bavarian population in
2009.Results
Similarity of the KORA study region and the district of
Middle Franconia
To ensure that the KORA study region and the district
of Middle Franconia reflect comparable populations, we
contrasted demographic information derived from
official Bavarian statistics for both regions with overall
Bavarian figures. As presented in Table 1, the char-
acteristics of the district of Middle Franconia resembled
quite well those of the Federal State of Bavaria in 2006,
which was also the case for the KORA study region in
2009.
Table 1 Official statistics on sociodemographics and morbidity: Comparison of KORA study region, district of Middle
Franconia and the Federal State of Bavaria
Variable Comparison of Middle Franconia (MFr) and
Bavaria (BY) in 2006
Comparison of KORA study region (KORA SR)
and Bavaria (BY) in 2009
Quota (%) BY Quota (%) MFr Odds ratio Quota (%) BY Quota (%) KORA SR Odds ratio
Sex
Male 41.9 41.7 1.00 42.8 42.7 1.00
Female 58.1 58.3 1.00 57.2 57.3 1.00
Age group (years)
65-69 33.4 33.2 1.01 28.8 29.6 0.97
70-74 23.8 23.8 1.00 27.5 27.1 1.01
75-79 18.8 19.0 0.99 18.3 18.4 0.99
80-84 13.9 13.8 1.01 13.9 13.9 1.00
85-89 7.0 7.0 1.00 8.4 8.2 1.02
90+ 3.2 3.2 1.00 3.0 2.8 1.07
Entitled to long-term care services*
Yes 2.5 2.4 1.02 2.6 2.3 1.10
No 97.5 97.6 1.00 97.5 97.7 1.00
Mean BY Mean MFr Delta Mean BY Mean KORA SR Delta
Hospital discharges per 1000 inhabitants* 198 199 –1 213 210 3
Length per hospital stay (days)* 8.4 8.7 −0.3 7.8 7.6 0.2
Source: Bavarian Office for Statistics and Data Processing.
*Figures refer to the entire resident population (all age groups).
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AOK Middle Franconia insured people
Of the 4,127 KORA-Age participants interviewed by
telephone, 2,015 (48.8%) were male. Mean age was
73.4 years (SD 6.1) with the oldest participant being
93 years old. The proportion of privately insured partici-
pants in the sample was 9.6%. In the AOK insurance
sample, 36,875 individuals (98.2%) were of German
nationality. Of those, 10,344 were male (28.1%), and the
mean age was 79.8 years.Entitlement to long-term care services
Table 2 shows that the likelihood of being entitled to
long-term care services – defined as any care levelTable 2 Age- and sex-specific entitlement to long-term care s
Males
Age group (years) 65–69 70–74 75–79
Entitlement to long-term
care services
KORA-Age* 1.2% 2.1% 6.4%
AOK SHI fund 2006 3.8% 6.3% 9.2%
Delta as a % −68% −67% −30%
KORA-Age† 1.0% 1.9% 6.0%
Bavaria 2009 2.4% 4.2% 8.0%
Delta as a % −59% −56% −25%
*Excluding KORA-Age participants with private health insurance.
†Including KORA-Age participants with private health insurance.assignment – increased steadily with age. Irrespective of
the chosen data source, it was about 10 times higher in
the oldest age group compared with the youngest one.
Across the entire age range, the AOK sample yielded
the highest quota of beneficiaries, but the difference
was small compared with the official statistics. The
KORA-Age sample continuously indicated a signifi-
cantly lower quota.
Figure 2 describes the distribution of care levels within
the three data sources, standardized for the Bavarian resi-
dent population of 2009. According to official statistics
and AOK data, around 50% of beneficiaries were mildly
dependent (care level 1), around 33% were moderately
dependent (care level 2) and around 15% were severely
dependent (care level 3). Within the KORA-Age sample,ervices
Females Age/sex
standard80–84 85–90 65–69 70–74 75–79 80–84 85–90
4.1% 13.6% 0.6% 1.6% 5.0% 12.7% 24.2% 5.0%
16.7% 28.1% 3.3% 4.7% 9.9% 23.4% 39.0% 10.5%
−75% −51% −82% −67% −50% −46% −38% −52%
4.1% 13.1% 0.6% 1.6% 4.9% 12.2% 24.4% 4.9%
14.8% 26.9% 2.1% 4.0% 9.5% 20.4% 39.1% 9.2%
−72% −51% −73% −60% −48% −40% −38% −47%
Figure 2 Percentage of individuals entitled to long-term care services. Percentage of individuals entitled to long-term care services; age-
and sex-standardized for the Bavarian resident population NA: Not applicable; Care level unknown or application for long-term care is under
consideration but not yet decided.
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care level 2 and less than 10% to care level 3.
Inpatient services
We compared self-reported inpatient days from the
KORA-Age study with extrapolated AOK data to assess
the volume of service use. As seen in Table 3, claimsTable 3 Age- and sex-specific mean in-hospital days, physicia
Age group (years) 65-69 70-74
Inhospital days KORA-Age 2.8 2.5
AOK SHI fund 2009* 2.4 4.9
Delta as a % 18% −49%
AOK SHI fund 2006 3.6 4.1
Delta 2006 as a % −22% −39%
Physician visits KORA-Age 9.2 9.5
AOK SHI fund 2009* 29.0 36.3
Delta as a % −68% −74%
AOK SHI fund 2006 28.2 33.3
Delta 2006 as a % −67% −71%
Number of drugs for treatment of
chronic conditions
KORA-Age 1.9 2.2
AOK SHI fund 2009* 2.3 2.5
Delta as a % −17% −9%
AOK SHI fund 2006 1.9 2.2
Delta 2006 as a % 2% 2%
*Extrapolated from 2006 data.data generally indicated more inpatient days per capita
than survey data. Irrespective of age, the difference be-
tween both data sources was more pronounced in male
participants. Standardized for the Bavarian resident
population, the volume of service utilization in the
KORA-Age sample was around one fifth lower (3.4 versus
4.3 in-hospital days).n visits and drugs for the treatment of chronic conditions
Males Females Age/sex
standard
75-79 80-84 85-90 65-69 70-74 75-79 80-84 85-90
3.1 3.3 5.4 3.7 2.7 3.7 4.0 5.1 3.4
5.1 5.5 7.0 3.7 3.2 5.1 5.0 5.7 4.3
−40% −40% −23% 1% −14% −27% −20% −11% −21%
4.5 5.1 5.3 2.3 3.4 4.0 4.6 5.3 3.9
−31% −35% 2% 63% −21% −7% −14% −3% −13%
10.7 12.7 13.2 9.8 10.7 11.4 14.4 13.0 10.9
38.7 39.8 43.0 33.0 36.2 39.2 37.4 40.5 35.9
−72% −68% −69% −70% −70% −71% −62% −68% −70%
36.0 37.1 38.4 30.1 32.3 33.8 36.2 38.2 33.1
−70% −66% −66% −68% −67% −66% −60% −66% −67%
2.8 2.9 2.9 1.9 2.2 2.6 3.0 3.1 2.4
2.8 2.8 3.3 2.3 2.5 3.0 3.1 3.5 2.7
0% 4% −12% −16% −9% −12% −5% −10% −9%
2.3 2.4 2.4 1.9 2.2 2.5 2.7 2.6 2.2
21% 24% 18% 3% 2% 6% 12% 21% 8%
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As presented in Table 3, female KORA-Age participants
reported slightly more physician contacts than their
male counterparts. Within the extrapolated AOK data
there was no such definite trend. Irrespective of age group
and sex the self-reported visits reached only 30–40% of
contacts as documented within claims. Standardized for the
Bavarian resident population, KORA-Age participants in-
curred about 10.9 physician visits per capita, but AOK
insurants incurred three times as many visits, namely 35.9.
Drugs for chronic conditions
Both KORA-Age and extrapolated AOK data suggested
that older age was associated with more intense pharma-
cological treatment of chronic conditions. Standardized
for the Bavarian resident population, we observed that
the number of prescribed drugs for the treatment of
chronic conditions in the KORA-Age study was about
9% lower than among the AOK insurants.
Sensitivity analysis for KORA-Age participants insured
by AOK
From the 4,127 KORA-Age participants, 1,105 (26.8%)
were insured by AOK at baseline. If utilization rates
were calculated for this subgroup only, estimates were
slightly higher than those for all SHI insurants (entitle-
ment to LTCI: 6.3%; mean inhospital days: 3.5; mean
physician visits: 10.9; mean number of drugs: 2.6).
Comparison between individuals with and without
diabetes
In the KORA-Age study, the age- and sex-adjusted
mean number of hospital days in individuals with drug-
treated diabetes (4.71; 95% CI: 3.52–5.90) was 1.49
times higher than in individuals without diabetes (3.16;
95% CI: 2.68–3.64). For the mean number of physician
visits, this ratio was 1.37 (diabetes: 14.24; 95% CI:
13.00–15.49; no diabetes: 10.35; 95% CI: 9.85–10.85).
Although the mean level of utilization was higher in
the AOK sample, the relative ratio of utilization between
individuals with and without diabetes was quite similar
to the KORA-Age estimates. The mean number of hos-
pital days for individuals with diabetes (5.54; 95% CI:
5.19–5.88) was 1.56 times higher than for individuals
without diabetes (3.55; 95 CI: 3.37–3.74). For the num-
ber of physician visits, the ratio was 1.40 (diabetes:
45.42; 95% CI: 44.67–46.17; no diabetes: 32.39; 95% CI:
31.99–32.80).
Discussion
Estimates of health care utilization from population sur-
veys are subject to non-response bias and recall bias. In
order to assess the extent of recall bias, it is necessary to
link self-reported data from survey participants withtheir individual claims data, whereas the investigation of
non-response bias requires the comparison of claims
data from participants and non-participants. In Germany,
as in many other countries, individual linkage is costly
and challenging. Moreover, obtaining data from non-
responders without their consent is prohibited by law.
The alternative chosen in the current study was to com-
pare survey-based estimates with external data. Thus, we
could only examine whether estimates obtained from the
survey over- or underestimate the ‘true’ amount of health
care utilization in the population, but could not exactly
determine the mechanisms behind these discrepancies.
Our study compared estimates obtained from the
KORA-Age study with official statistics on LTCI and with
estimates from an independent SHI sample. As the KORA
study region may not be fully representative of Germany
as a whole, we compared the survey data with regional
(i.e. for the state of Bavaria) instead of national official sta-
tistics. Also, the claims data refer to the market-leading
Bavarian SHI fund and may therefore be more suitable for
comparison than data from a nationwide SHI fund. It
should be noted that the claims data and the survey data
refer to different regions in the state of Bavaria. However,
the comparison of demographics and overall health care
utilization rates suggested that there were no fundamental
differences between the two regions and Bavaria as a
whole. Thus, it can indirectly be concluded that there is
also no difference between both regions.
Our results showed that the KORA-Age study under-
estimated the mean utilization of long-term care, out-
patient and inpatient services, whereas the estimated
utilization of pharmaceuticals was very close to the
comparative claims data. Although the design of our
study does not allow disentangling recall bias from non-
response bias, the discrepancies in some domains may
be more likely to result from poor recall than non-
response, and vice versa. For example, one can assume a
rather high recall of long-term care entitlement because
care level assignment requires a standardized medical
examination by trained physicians from the Medical
Review Board of the SHI funds performed either at the
applicants’ home or in the nursing home [35]. Thus, the
small proportion of individuals entitled to long-term
care services in KORA-Age is probably caused by a
higher rate of non-participation among these subjects,
which apparently in particular affects higher care levels.
The true proportion was underestimated, although we
also arranged home visits and proxy interviews in order
not to exclude those needing a high level of care, espe-
cially those living in nursing homes. In total, 27 indivi-
duals among the KORA-Age participants lived in a
nursing home, and data from 22 of them came from a
proxy interview with either a family member or a pro-
fessional care giver.
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picture is less clear. Although several studies observed
that individuals have a good recall of major and rare
events such as hospitalizations [2,7], patients may not
accurately recall the length of hospital stay [36].
Consistent with previous findings, the self-reported
number of physician visits in our study underestimated
the mean utilization rates documented in the claims data
[37-39]. Research by Glandon et al. [40] focusing on the
older population found that individuals tended to under-
report the volume of outpatient services by 10.4%. This
underreporting level was much less pronounced than in
our study, which may be due in part to the different
levels of utilization. Previous work has shown that the
extent of underreporting increases with increasing
utilization [37]. Whereas the mean number of physician
visits in a 6-month period was 3.38 in the study by
Glandon et al., the corresponding number in the AOK
claims data was five times higher. Owing to the limited
interview time, the KORA-Age study only used a single
question to assess outpatient services. Individuals may
better recall past utilization if they are asked to report
separately the visits to general practitioners and to dif-
ferent medical specialists. Unpublished results from a
former KORA study in the age group between 65 and
85 years showed that respondents reported on average a
1.5 times higher number of physician visits if questions
distinguished between 15 different medical specialities.
However, even when multiplying the estimates of phys-
ician visits from the KORA-Age sample by 1.5, the
underestimation is still substantial compared with claims
data. This may partly be explained by the fact that
respondents may forget to report physician visits that do
not require direct patient–physician interaction such as
picking up a repeat prescription.
Comparing survey and insurance data on drug use, we
found similar estimates on the overall level as well as
within age groups. As our survey question covered current
medicine, recall bias can be expected to be absent [29].
Also, the question was part of the postal questionnaire so
that participants were asked to list not only the names of
currently used drugs but also the PZN written on the
package. This allowed a thorough identification and a pre-
cise coding according to the ATC code. Therefore, one
can assume a high validity of self-reports in our study.
This is in line with previous research suggesting high
agreement between self-reported use of drugs to treat
chronic conditions and individually linked insurance data
[29,30]. As a consequence, it is likely that the small differ-
ences between survey and insurance observed in our data
are mainly due to non-response bias.
Previous research on the impact of non-response on
health care utilization estimates showed no consistent
results. Although according to some studies non-respondents tend to have higher health care utilization
rates than responders, especially in the older population
[8,9], other studies observed no substantial difference
[16].
There are considerable discrepancies between self-
reports and claims data when estimating mean utilization
levels of inpatient and outpatient services. Nevertheless,
we found that surveys in the elderly may still validly esti-
mate differences in utilization existing between different
groups of individuals. For example, the ratio of mean
utilization between individuals with and without drug-
treated diabetes in the KORA-Age study was nearly the
same as in the claims data. This suggests that estimating
ratios instead of absolute differences may be more appro-
priate in such data. Concentrating on ratios might also en-
hance comparisons between different countries, where
absolute utilization rates are expected to differ because of
differently designed health care systems.
Our study had some limitations. AOK Bavaria is the
leading SHI fund in Middle Franconia; however, its cli-
entele may not be representative of all SHI insurants in
the district. In particular, it is known that for historical
reasons, AOK insures a comparatively high quota of
low-income individuals [41]. As a positive association
between economic situation and health status is gener-
ally accepted, it is possible that estimates based on the
AOK sample overestimate the true average health care
consumption in the population. For example, we
observed that the proportion of individuals entitled to
LTCI services was slightly higher compared with the
official statistics. Also, our sensitivity analysis showed
that KORA-Age participants insured by AOK had a
slightly higher use of health services than participants
insured by other SHI funds. However, it must be noted,
that due to the industrial history of the KORA study re-
gion, many people are enrolled in company health insur-
ance funds. Accordingly, only about one in four KORA-
Age participants was insured by AOK. As a conse-
quence, estimates from the sensitivity analysis have more
uncertainty, and this holds especially for the entitlement
to LTCI, where cell counts for age and sex groups were
very small. Also, it must be noted that we used the infor-
mation on health insurance funds from the baseline sur-
veys, so that some participants might have switched
their sickness fund in the meantime. However, there is
some evidence from a former KORA study that this does
not apply to middle-aged and older age groups to any
great extent [42].
Although differences between AOK and other SHI
funds with regard to the prevalence of chronic diseases
have been reported in the literature [43,44], published
age- and sex-specific health care utilization rates from
another large German SHI were very close to those of
AOK Middle Franconia [25,26].
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and KORA-Age data mainly to 2009. As published offi-
cial statistics indicated an increase in utilization in some
domains during this 3-year period, we applied specific
extrapolation methods in order to achieve comparability.
Although the method used to extrapolate drug
utilization was based on very detailed official statistics
about the specific increase in each age and ATC group,
we did not have comparable information for the in-
patient and outpatient domains. Thus, we assumed con-
stant annual growth rates and extrapolated the increase
between 2006 and 2007 observed in the claims data for
each sex and age group. However, this rough calculation
cannot take into account external events such as
changes in the legal framework that may have occurred
in the meantime. However, the comparison with unex-
trapolated 2006 data also revealed a considerable degree
of underreporting in the survey.
Conclusion
In conclusion, our findings suggest that survey estimates
based on self-report tend to underestimate the true level
of health care utilization in the older population. This
especially affects the frequency of physician visits and
the entitlement to long-term care services. In contrast,
the assessment of drug consumption by postal self-
report questionnaires yields similar estimates to the ana-
lysis of comparative insurance claims data. In order to
disentangle recall from non-response bias, additional
direct validation studies linking self-reported and claims
data at an individual level are urgently needed. In the
long run, corresponding analyses will allow the calcula-
tion of age-and sex-specific correction factors.
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